COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma.

In conclusion, COX-2 expression in ameloblastomas is not associated with MVD, but it is significantly associated with recurrences and with a lower DFS.
PMID: 29559247 [PubMed - as supplied by publisher]

Source: Pathology, Research and Practice - March 15, 2018 Category: Pathology Authors: Montezuma MAP, Fonseca FP, Benites BM, Soares CD, do Amaral-Silva GK, de Almeida OP, Soares FA, Pagano RL, Fregnani ER Tags: Pathol Res Pract Source Type: research